Sodium binding to hH3R and hH4R — a molecular modeling study

Journal of Molecular Modeling

Volumn 20, Issue 8, 2014, Pages 1-11

  Wittmann, Hans Joachim ^a   Seifert, Roland ^b   Strasser, Andrea ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Allosteric binding site; GPCR; hH3R; hH4R; Sodium sensitivity; Subtype differences

Indexed keywords

ADENOSINE A2A RECEPTOR; AMINO ACID; ASPARTIC ACID; G PROTEIN COUPLED RECEPTOR; GLUTAMINE; GLYCINE; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; OXYGEN; SERINE; SODIUM; SODIUM ION; CYSTEINE; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN; ION; MUTANT PROTEIN; SODIUM CHANNEL; SOLVENT;

ALLOSTERISM; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; SIMULATION; SITE DIRECTED MUTAGENESIS; SOLVATION; STEREOSPECIFICITY; CHEMICAL STRUCTURE; CHEMISTRY; EXTRACELLULAR SPACE; HUMAN; METABOLISM; PROTEIN CONFORMATION; STATIC ELECTRICITY; THERMODYNAMICS;

CYSTEINE; EXTRACELLULAR SPACE; HUMANS; IONS; MODELS, MOLECULAR; MUTANT PROTEINS; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; RECEPTORS, HISTAMINE H3; SODIUM; SODIUM CHANNELS; SOLVENTS; STATIC ELECTRICITY; THERMODYNAMICS;

EID: 84905326897     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-014-2394-2     Document Type: Article

References (41)

1. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, Harmar AJ (2005) International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57:279–288
2. Wise A, Gearing K, Rees S (2002) Target validation of G-protein coupled receptors. Drug Discov Today 7:235–246
3. Jacoby E, Bouhelal R, Gerspacher M, Seuwen K (2006) The 7TM G-protein-coupled receptor target family. Chem Med Chem 1:760–782
4. Hill SJ, Ganellin CR, Timmermann H, Schwartz JC, Shankley NP, Young JM et al. (1997) International Union of Pharmacology XIII. Classification of histamine receptors. Pharmacol Rev 49:253–278
5. 4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov 7:41–53
6. 4 receptors as novel drug targets. Expert Opin Investig Drugs 18:1519–1531
7. Leurs R, Vischer HF, Wijtmans M, de Esch IJ (2011) En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family. Trends Pharmacol Sci 32:250–257
8. Strasser A, Wittmann HJ, Buschauer A, Schneider EH, Seifert R (2013) Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs. Trends Pharmacol Sci 34:13–32
9. Seifert R, Strasser A, Schneider EH, Neumann D, Dove S, Buschauer A (2013) Moleclar and cellular analysis of human histamine receptor subtypes. Trends Pharmacol Sci 32:33–58
10. Lefkowitz RJ, Cotecchia S, Samama P, Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303–307
11. Leff P (1995) The two-state model of receptor activation. Trends Pharmacol Sci 16:89–97
12. Schütz W, Freissmuth M (1992) Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol Sci 13:376–380
13. Seifert R, Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild type receptors. Naunyn Schmiedeberg's Arch Pharmacol 366:381–416
14. Seifert R, Wenzel-Seifert K (2003) The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors. Life Sci 73:2263–2280
15. + as universal stabilizer of the inactive (R) state. Receptor Channels 7:357–369
16. Martin S, Botto JM, Vincent JP, Mazella J (1999) Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors. Mol Pharmacol 55:210–215
17. 2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding. J Pharmacol Exp Ther 328:40–54
18. Schetz JA (2005) Allosteric modulation of dopamine receptors. Mini Rev Med Chem 5:555–561
19. 2 receptors by sodium and pH. Mol Pharmacol 39:570–578
20. 3 receptor function by monovalent ions. Neuroscience Lett 472:114–118
21. 4 receptor ligands. Biochem Pharmacol 78:607–616
22. 2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol Pharmacol 39:733–739
23. 4 dopamine receptor is coupled to three distinct sites of allosteric modulation. J Pharmacol Exp Ther 296:359–363
24. Ceresa BP, Limbird LE (1994) Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of α2-adrenergic receptor-G-protein interactions. J Biol Chem 269:29557–29564
25. Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Katritch V, Han GW, Roth CB, Heitman LH, Ijzerman AP, Cherezov V, Stevens RC (2012) Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337:232–235
26. Selent J, Sanz F, Pastor M, De Fabritiis G (2010) Induced effects of sodium ions on dopaminergic G-protein coupled receptors. Plos Comput Chem 6:e10000884
27. Yuan S, Vogel H, Filipek S (2013) The role of water and sodium ions in the activation of the μ-opioid receptor. Angew Chem Int Ed 52:10112–10115
28. 1 receptor complex with doxepin. Nature 475:65–70
29. 2R-Gαβγ-homodimer. J Mol Model 19:4443–4457
30. Angel TE, Chance MR, Palczewski K (2009) Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors. PNAS 106:8555–8560
31. 2-adrenergic G protein-coupled receptor. Science 318:1258–1265
32. 4-receptor selectivity. Naunyn Schmiedeberg's Arch Pharmacol. doi:10.1007/s00210-013-0926-4
33. Humphrey W, Dalke A, Schulten K (1996) VMD – visual molecular dynamics. J Mol Graphics 14:33–38
34. Oostenbrink C, Villa A, Mark AE, van Gunsteren WF (2004) A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem 25:1656–1676
35. Straatsma TP, Mc Cammon JA (1991) Multiconfiguration thermodynamic integration. J Chem Phys 95:1175–1188
36. Villa A, Mark AE (2002) Calculation of the free energy of solvation for natural analogs of amino acid side chains. J Comput Chem 23:548–553
37. 4R – a pharmacological and molecular modelling study. Naunyn-Schmiedeberg’s Arch Pharmacol 384:287–299
38. 3 receptor. In silico pharmacology, accepted
39. 2 Zinc-finger. J Am Chem Soc 130:892–900
40. 1-receptor. J Pharmacol Exp Ther 326:783–791
41. 3 receptor heterogeneity. Neuropharmacology 44:773–786